{
  "casebody": {
    "status": "ok",
    "data": "<?xml version='1.0' encoding='utf-8'?><html><body><casebody firstpage=\"1761\" lastpage=\"1761\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties id=\"p-1\">TEVA PHARMACEUTICALS USA, INC., et al., petitioners,<br/> v.<br/> SANDOZ INC., et al.</parties>\n<docketnumber id=\"p-2\">No. 13-854.</docketnumber>\n<court id=\"p-3\">Supreme Court of the United States</court>\n<decisiondate id=\"p-4\">March 31, 2014.</decisiondate>\n\n\n\n<opinion type=\"majority\"><p id=\"p-5\">Case below, <extracted-citation case-ids=\"4065641\" index=\"0\" url=\"https://cite.case.law/f3d/723/1363/\">723 F.3d 1363</extracted-citation>.</p><p id=\"p-6\">Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit granted.</p></opinion></casebody>\n</body></html>"
  }
}